RENAL CARCINOMA RADICAL NEPHRECTOMY C64
Conditions
Interventions
Group 1: study group : 0.125% Bupivacaine hydrochloride loading dose 20ml and 0.125% bupivacaine hydrochloride at the rate of 8ml/hr as post operative infusion
Group 2: Control group : 0.9% Normal S
Sponsors
Department of AnaesthesiologyBasavataram Indo American Cancer Hospital & Research Institute
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: The patients of ASA grade I and II undergoing radical nephrectomy with unilateral abdominal incision. Patient included in the study will be between ages of 18 to 65 years
Exclusion criteria
Exclusion criteria: Patients unable or unwilling to give informed consent. Those with a history of relevant drug allergy, patients currently using other analgesics or who had current acute or chronic pain or were receiving medical therapies considered to result in tolerance to opioids. Patients with deranged coagulation profile severe hepatic, renal dysfunction, and infection at the injection site. Mid line abdominal incision is also excluded as it will require a bilateral Quadrarus Lumborum Block.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| morphine consumption in first 48 Hrs | — |
Secondary
| Measure | Time frame |
|---|---|
| Heamodynamic: Heart rate / Blood Pressure / SPO2 / Respiratory Rate Post Operative Nausea Vomiting scoring Ramsay sedation Scoring for first 48 hrs | — |
Countries
India
Contacts
Public ContactSRINIVASA SHYAM PRASAD MANTHA
BASAVATARAKAM INDO AMERICAN CANCER HOSPITAL & RESEARCH INSTITUTE
Outcome results
None listed